Abstract
This cohort study analyzed inpatient data from multiple US hospitals to characterize patients with and without coronavirus disease (COVID-19) who had diabetic ketoacidosis.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Acid-Base Equilibrium
-
Acute Kidney Injury / epidemiology
-
Adult
-
Age Distribution
-
Age Factors
-
Aged
-
Blood Glucose / metabolism
-
COVID-19 / complications
-
COVID-19 / epidemiology*
-
Cardiovascular Diseases / epidemiology
-
Case-Control Studies
-
Comorbidity
-
Diabetes Complications / epidemiology
-
Diabetic Ketoacidosis / complications
-
Diabetic Ketoacidosis / drug therapy
-
Diabetic Ketoacidosis / metabolism
-
Diabetic Ketoacidosis / mortality*
-
Female
-
Glycated Hemoglobin / metabolism
-
Hospital Mortality*
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Insulin / therapeutic use
-
Male
-
Middle Aged
-
Obesity / epidemiology
-
SARS-CoV-2
-
United States / epidemiology
Substances
-
Blood Glucose
-
Glycated Hemoglobin A
-
Hypoglycemic Agents
-
Insulin
-
hemoglobin A1c protein, human